Tharimmune Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company’s early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
/ 
Frequently asked questions
To buy Tharimmune Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Tharimmune Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Tharimmune Inc. is THAR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Tharimmune Inc. has its primary listing on NASDAQ (Small cap). You can trade Tharimmune Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Tharimmune Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Tharimmune Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Tharimmune Inc..